These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 39241935)
1. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials. Musazadeh V; Assadian K; Rajabi F; Faghfouri AH; Soleymani Y; Kavyani Z; Najafiyan B Pharmacol Res; 2024 Oct; 208():107398. PubMed ID: 39241935 [TBL] [Abstract][Full Text] [Related]
2. Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials. Ebrahimzadeh A; Mohseni S; Safargar M; Mohtashamian A; Niknam S; Bakhoda M; Afshari S; Jafari A; Ebrahimzadeh A; Fooladshekan S; Mohtashami A; Ferns GA; Babajafari S; Sohrabi Z Complement Ther Med; 2024 Mar; 80():103025. PubMed ID: 38232906 [TBL] [Abstract][Full Text] [Related]
3. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257 [TBL] [Abstract][Full Text] [Related]
4. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558 [TBL] [Abstract][Full Text] [Related]
5. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P Front Nutr; 2022; 9():880014. PubMed ID: 35669067 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Pan Y; Yang Y; Wu J; Zhou H; Yang C BMC Gastroenterol; 2024 Aug; 24(1):283. PubMed ID: 39174901 [TBL] [Abstract][Full Text] [Related]
8. The effect of melatonin supplementation on liver indices in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials. Mansoori A; Salimi Z; Hosseini SA; Hormoznejad R; Jafarirad S; Bahrami M; Asadi M Complement Ther Med; 2020 Aug; 52():102398. PubMed ID: 32951697 [TBL] [Abstract][Full Text] [Related]
9. The effects of probiotic supplementation and exercise training on liver enzymes and cardiometabolic markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials. Kazeminasab F; Miraghajani M; Mokhtari K; Karimi B; Rosenkranz SK; Santos HO Nutr Metab (Lond); 2024 Aug; 21(1):59. PubMed ID: 39090657 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta-analysis. Saadati S; Naseri K; Asbaghi O; Yousefi M; Golalipour E; de Courten B Obes Rev; 2024 Mar; 25(3):e13667. PubMed ID: 38030409 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. Hadi A; Mohammadi H; Miraghajani M; Ghaedi E Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449 [No Abstract] [Full Text] [Related]
12. GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Rezaei S; Tabrizi R; Nowrouzi-Sohrabi P; Jalali M; Atkin SL; Al-Rasadi K; Jamialahmadi T; Sahebkar A Can J Gastroenterol Hepatol; 2021; 2021():8936865. PubMed ID: 34805029 [TBL] [Abstract][Full Text] [Related]
13. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Sun L; Deng C; Gu Y; He Y; Yang L; Shi J Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843 [TBL] [Abstract][Full Text] [Related]
14. Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Arabi SM; Bahrami LS; Rahnama I; Sahebkar A Pharmacol Res; 2022 Feb; 176():106061. PubMed ID: 34999222 [TBL] [Abstract][Full Text] [Related]
15. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials. Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Zhu Y; Xu J; Zhang D; Mu X; Shi Y; Chen S; Wu Z; Li S Front Endocrinol (Lausanne); 2021; 12():769069. PubMed ID: 34956080 [TBL] [Abstract][Full Text] [Related]
17. The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. Guan L; Miao P Eur J Pharmacol; 2020 Oct; 885():173533. PubMed ID: 32871172 [TBL] [Abstract][Full Text] [Related]
18. Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials. Saleh SAK; Santos HO; Găman MA; Cerqueira HS; Zaher EA; Alromaih WR; Arafat NS; Adi AR; Adly HM; Alyoubi R; Alyahyawi N; Kord-Varkaneh H Clin Nutr ESPEN; 2024 Feb; 59():70-80. PubMed ID: 38220409 [TBL] [Abstract][Full Text] [Related]
19. The effect of vitamin D2 on lipid profile, anthropometric indices, blood pressure, and inflammatory and glycemic biomarkers in humans: A systematic review and meta-analysis of randomized controlled trials. Zhou Z; Liu J; Zhang H; Prabahar K; Hernández-Wolters B; Yuan Y Prostaglandins Other Lipid Mediat; 2024 Oct; 174():106883. PubMed ID: 39154789 [TBL] [Abstract][Full Text] [Related]
20. Effect of plum supplementation on blood pressure, weight indices, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Ghalandari H; Askarpour M; Setayesh L; Ghaedi E Clin Nutr ESPEN; 2022 Dec; 52():285-295. PubMed ID: 36513468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]